Recently, we conducted a technical evaluation for ADAPT Pharma, Inc. In the evaluation we compared two delivery methods for the opioid overdose reversal drug naloxone—NARCAN® Nasal Spray and a naloxone prefilled syringe with a nasal atomizer (PFS-NA). We found that the level of task complexity and number of steps within those tasks were substantially greater for PFS-NA than for the nasal. Read more
